Role of the NF-κB Signalling Pathway in the Pathophysiology in Depression
International Journal of Innovative Science and Research Technology · 16.05.2026 · 274
DOI: 10.38124/ijisrt/26may354 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Innovative Science and Research Technology, online erschienen am 16.05.2026. Verfasst von Nitu . und 6 weiteren Autor:innen. Die Arbeit nennt 82 Literaturangaben.
Themen: Depression
Abstract (Originalsprache)
Introduction: Depression is a multifactorial psychiatric disorder closely associated with chronic inflammation and stress. The nuclear factor kappa-B (NF-κB) signalling pathway, a major regulator of immune and inflammatory responses, has emerged as a key molecular link between these factors and depression. Under chronic stress, NF-κB becomes over activated in neurons and glial cells, promoting the release of pro-inflammatory cytokines such as IL-1β, IL-6, and TNF-α. This heightened inflammatory response contributes to oxidative stress, neuronal dysfunction, and reduced neuroplasticity—central features of depressive disorders. Methods: This study employed a comprehensive literature review approach to investigate the role of the NF-κB signaling pathway in the pathophysiology of depression. The search used keywords such as “NF-κB,” “depression,” “inflammation,” “cytokines,” and “BDNF.” Both experimental (animal and cellular) and clinical studies were included to evaluate molecular mechanisms linking NF-κB activation with depressive symptoms. Results: This review shows that NF-κB overactivation increases cytokines and oxidative stress, causing neuronal dysfunction. The Notch2/NF-κB pathway increases stress susceptibility, while NF-κB inhibition reduces depressive behaviours, suggesting therapeutic potential. Conclusion: NF-κB overactivation links inflammation and depression by impairing neuroplasticity and hormonal balance. Targeting this pathway may help reduce neuroinflammation and improve depressive symptoms. Further research should explore NF-κB inhibitors in clinical settings.
Zitieren
APA
., N., Garg, A., Gopika, S., Upadhayay, A., Singh, Y., Tanwar, B., & ., C. (2026). Role of the NF-κB Signalling Pathway in the Pathophysiology in Depression. International Journal of Innovative Science and Research Technology, 274. https://doi.org/10.38124/ijisrt/26may354
Vancouver
. N, Garg A, Gopika S, Upadhayay A, Singh Y, Tanwar B, et al. Role of the NF-κB Signalling Pathway in the Pathophysiology in Depression. International Journal of Innovative Science and Research Technology. 2026:274. doi:10.38124/ijisrt/26may354
BibTeX
@article{2026,
author = {., Nitu and Garg, Arun and Gopika, S. and Upadhayay, Ashutosh and Singh, Yogender and Tanwar, Badal and ., Chetna},
title = {Role of the NF-κB Signalling Pathway in the Pathophysiology in Depression},
journal = {International Journal of Innovative Science and Research Technology},
year = {2026},
pages = {274},
doi = {10.38124/ijisrt/26may354}
}
EUVIMED